7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

ContraFect Corporation
(NASDAQ:CFRX) 

CFRX stock logo

ContraFect Corporation, a clinical-stage biotechnology company, focuses on the discovery and development of therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead product candidates consist of CF-301, an i...

Founded: 2008
Full Time Employees: 24
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
ContraFect Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -88.18-75.58-62.99-50.39-37.79-25.19-12.60
ContraFect Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -88.26-75.65-63.05-50.44-37.83-25.22-12.610
ContraFect Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 05.1310.2615.3820.5125.6430.7735.89
ContraFect P/S ratio ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.240.470.710.951.191.421.66
ContraFect (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.16-0.14-0.12-0.09-0.07-0.05-0.020
ContraFect P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.64-2.16-1.68-1.19-0.71-0.230.250.73
No extra charts and metrics for this ticker.